Results 271 to 280 of about 148,658 (326)

Interleukin‐24: A Multidimensional Therapeutic for Treatment of Human Diseases

open access: yesWIREs Nanomedicine and Nanobiotechnology, Volume 17, Issue 3, May/June 2025.
The discovery of interleukin (IL)‐24 and studying its biological activity demonstrate its potential to serve as a therapeutic for human diseases, especially for cancer treatment. Image created with BioRender.com. ABSTRACT The field of targeted therapy exploits the selective expression of therapeutic genes or proteins in diseased cells.
Rajeswari Raguraman   +2 more
wiley   +1 more source

Real‐World Insights From Türkiye: Biologic DMARDs Usage in Spondyloarthritis Patients With Chronic Kidney Disease

open access: yesInternational Journal of Rheumatic Diseases, Volume 28, Issue 5, May 2025.
ABSTRACT Aim The objective was to evaluate biologic disease‐modifying antirheumatic drugs (DMARDs) and their side effects that hindered the continuation of treatment in a patient population diagnosed with spondyloarthritis (SpA) with a glomerular filtration rate (GFR) ≤ 60 mL/min, and to compare these side effects between patients with chronic kidney ...
Dilara Bulut Gökten   +23 more
wiley   +1 more source

The microbiome and HLA-B27-associated acute anterior uveitis

open access: yesNature Reviews Rheumatology, 2018
J. Rosenbaum, M. Asquith
semanticscholar   +1 more source

The ever ongoing cosmetic quest to change eye colour

open access: yesActa Ophthalmologica, Volume 103, Issue 3, Page 357-362, May 2025.
Abstract Purpose To provide a historical overview of the various efforts to change eye colour for purely cosmetic reasons, along with the associated potential risks and harms. Methods Literature and online search. Results Eye drops containing adrenaline were used during World War II on involuntary inmates of concentration camp Auschwitz‐Birkenau ...
Richard H. C. Zegers
wiley   +1 more source

Clinical features and outcomes of horses presenting with presumed equine immune mediated keratitis to two veterinary hospitals in the United Kingdom and Finland: 94 cases (2009–2021)

open access: yesEquine Veterinary Journal, Volume 57, Issue 3, Page 598-610, May 2025.
Abstract Background There is limited literature regarding equine immune mediated keratitis (IMMK) in Europe. North America‐based publications describe minimal blepharospasm, rare corneal ulceration and no uveitis; clinical impression suggests these are seen in Europe. Objectives Assess the prevalence of blepharospasm, corneal ulceration and uveitis and
Juliette F. Preston   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy